Navigation Links
ADVENTRX Reports Second Quarter 2011 Financial Results
Date:8/8/2011

iming of initiating clinical studies of ANX-188 and ANX-514. Actual events or results may differ materially from those expressed or implied by the forward-looking statements in this press release due to a number of risks and uncertainties, including, without limitation: the risk that ADVENTRX does not receive FDA approval of Exelbine on a timely basis, or at all; the potential for the FDA to impose requirements to be completed before or after approval of the Exelbine NDA; difficulties or delays in marketing Exelbine, if approved, including developing or acquiring additional marketing, sales and distribution capabilities; difficulties or delays in manufacturing Exelbine at commercial scale, if approved, including validating commercial manufacturing processes and manufacturers, as well as other suppliers, and the risk of supply shortages; the risk that Exelbine, if approved, does not achieve broad market acceptance, including as a result of limited differentiation (or ability to promote differentiation) from Navelbine® and its generic equivalents; the risk that Exelbine cannot be priced at levels that exceed its fully-burdened manufacturing cost or that provide a reasonable return on investment to ADVENTRX; the risk that any patent issued to ADVENTRX may not provide sufficient protection and market exclusivity for Exelbine and may be challenged, invalidated, infringed or circumvented by third parties, including by ADVENTRX's competitors; ADVENTRX's dependence on the success of Exelbine as its first product candidate to be submitted for regulatory approval; difficulties or delays in reaching agreement with the FDA on the clinical development of ANX-188 and ANX-514; the potential for the FDA to require significant additional clinical and/or nonclinical studies of ADVENTRX's lead product candidates, in addition to its planned clinical trials of ANX-188 and ANX-514, and that ADVENTRX consequently determines to discontinue one or more of those development programs; di
'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ADVENTRX Pharmaceuticals to Present at the 31st Annual Canaccord Genuity Growth Conference on August 11
2. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
3. ADVENTRX Reports First Quarter 2011 Financial Results
4. ADVENTRX Completes Acquisition of SynthRx
5. ADVENTRX Pharmaceuticals Provides Update on ANX-514
6. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
7. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
8. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
9. ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
10. ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing
11. ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Oct. 1, 2014   Plexus ... provider of Anesthesia Information Management Systems (AIMS), announced ... LLC , a wholly owned subsidiary of Quality ... information systems and connectivity solutions.  ... http://photos.prnewswire.com/prnh/20140930/149407 This partnership extends ...
(Date:10/1/2014)... NeuroCall, Inc., ("NeuroCall") announced today that it recently received ... Dr. Ricardo Garcia-Rivera , Founder and Chief Medical ... our quality of service has been recognized by The ... and continuity of care to patients of our expanding ... States ." NeuroCall currently provides ...
(Date:10/1/2014)... , Oct. 1, 2014 Quantum ... scaling volume production of photoactive quantum dots for ... . While offering numerous advantages for solar power ... large quantities of quantum dots with which to ... kept them from commercial utilization and acceptance. The ...
Breaking Medicine Technology:Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 2Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 3NeuroCall Awarded Joint Commission Accreditation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3
... The Leukemia & Lymphoma,Society has awarded a $550,000 grant ... Cancer Center at the University of Rochester Medical,Center. Millennium ... the first two years of the five-year program., ... support,Dr. Friedberg,s work on a new targeted treatment for ...
... Medivation, Inc.,(Nasdaq: MDVN ) today announced that ... on Monday, July 7, to discuss top-line results ... of,dimebon(TM) in Huntington,s disease., Teleconference/Webcast Details, ... July 7, at 5:00 p.m. Eastern,time by telephone, ...
Cached Medicine Technology:University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society 2Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2
(Date:10/2/2014)... WEDNESDAY, Oct. 1, 2014 (HealthDay News) -- Genes may interact ... new study suggests. The genetic risk occurs in about ... white. The finding could help these people reduce their heart ... healthy diet and stress management, the Duke University researchers said. ... people and found a strong link between variations in the ...
(Date:10/2/2014)... Thompson HealthDay Reporter ... pull out all the stops to rescue surgical patients ... the cost of such heroism is questionable, a new ... percent better at saving elderly patients with life-threatening complications ... less intensity, said senior author Dr. Amir Ghaferi. He ...
(Date:10/1/2014)... An international team of scientists has shown that more ... treated with existing drugs. , The study found that ... cancers with a genetic mutation that is present in ... JAK inhibitors are currently used, or are in clinical ... and myeloproliferative disorders. , Bowel cancer is the second-most ...
(Date:10/1/2014)... policy focus on expanding access to care for ... to have significant dental disease. In this month,s ... Dental Association , researchers from Tufts University School ... Medicine report on the first large-scale survey to ... caregivers to adults with developmental disabilities. The study ...
(Date:10/1/2014)... Bedros Keuilian is not only the founder ... camps, he’s also considered the leading expert on marketing ... business summits, a line of high-demand fitness marketing systems ... Spike TV reality show to his name. , With ... for personal trainers and fitness business owners to focus ...
Breaking Medicine News(10 mins):Health News:Genes May Make Some More Prone to Heart Disease When Under Stress 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3
... issues in war-torn African countries are subjects close to ... of nursing at the University of WisconsinMilwaukee (UWM) who ... on improving health care delivery in war-torn African countries. ... African Countries," is a case study of Buseh,s home ...
... 22 /PRNewswire/ -- Stern ... just helped launch its new client www.healthcarebluebook.com ... fair prices in their zip code for healthcare ... and science information into strategic communications resources and ...
... than $3.0 BillionSYDNEY, Australia and BEDMINSTER, N.J., Jan. 22 ... QRXPY), a clinical-stage specialty pharmaceutical company focused on the ... nervous system (CNS) disorders, announced today that Jesus Soriano, ... Dr. Soriano brings more than 17 years of experience ...
... key role in helping new mothers to share experiences and ... of the UK-based Journal of Advanced Nursing . , ... Assistant Professor Valerie Irvine from the University of Victoria, Canada, ... who had all given birth in the same year and ...
... Online Resource Emphasizes Safety Products and Support ServicesBETHLEHEM, ... Braun) has launched a new Web site exclusively ... for home infusion therapy (HIT).(LOGO: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ... a fast and easy way for home healthcare ...
... Health Partnership - It,s In Our Hands - Has ... Patients And Caregivers To Healthcare Resources And Services In ... initiation of its Community Health Partnership (CHP), It,s ... to link African American residents with local healthcare professionals ...
Cached Medicine News:Health News:Book examines heath care delivery in war-torn Africa 2Health News:Book examines heath care delivery in war-torn Africa 3Health News:Stern Communications Wins and Helps Launch Healthcarebluebook.com 2Health News:QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President 2Health News:QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President 3Health News:QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President 4Health News:Community-based Internet forums are great for new mothers, but could marginalize fathers 2Health News:Community-based Internet forums are great for new mothers, but could marginalize fathers 3Health News:B. Braun Medical Inc. Launches Home Infusion Therapy Web Site 2Health News:Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care 2Health News:Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care 3
Bravo Vacuum Pump Accessories Kit (One canister, one lid, one "O" ring tube, one tubing set)...
Bravo pH capsule with delivery system....
Buffer solution is needed to calibrate pH catheters. The specific chloride ion concentration in the Medtronic buffers is required for proper function of your Medtronic pH measurement system. Buffer s...
Buffer solution is needed to calibrate pH catheters. The specific chloride ion concentration in the Medtronic buffers is required for proper function of your Medtronic pH measurement system. Buffer s...
Medicine Products: